Skip to main content

UBS Group AG

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1610520 ZURICH, V8

Position in VRCA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$37,153
+$14,566 QoQ
Shares Held
6,071
+42.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. VRCA ranks #405 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRCA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,153 6,071
2026-03-31 $22,587 4,270
2025-12-31 $199 24
2025-09-30 $179,433 41,632
2025-06-30 $38,546 72,730
2025-03-31 $349,251 790,163
2024-12-31 $121,843 174,062
2024-09-30 $13,929 9,607
2024-06-30 $46,239 6,343
2024-03-31 $132,205 22,332
2023-12-31 $177,780 24,287
2023-09-30 $43,224 11,126
2023-06-30 $74,790 12,962
2023-03-31 $11,388 1,752
2022-12-31 $5,258 1,912
2022-09-30 $16,089 5,510
2022-06-30 $6,552 3,413
2022-03-31 $22,789 2,810
2021-12-31 $39,964 4,363
2021-09-30 $48,075 3,846
2021-06-30 $86,286 7,636
2021-03-31 $150,302 9,921
2020-12-31 $70,291 6,107
2020-09-30 $24,210 3,128
2020-06-30 $80,857 7,344
2020-03-31 $120,055 10,984